R
Rasnik Singh
Researcher at University of California, San Francisco
Publications - 31
Citations - 2416
Rasnik Singh is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Psoriasis & Microbiome. The author has an hindex of 14, co-authored 30 publications receiving 1581 citations. Previous affiliations of Rasnik Singh include Yale University & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Influence of diet on the gut microbiome and implications for human health.
Rasnik Singh,Hsin Wen Chang,Di Yan,Kristina Lee,Derya Ucmak,Kirsten Wong,Michael Abrouk,Benjamin Farahnik,Mio Nakamura,Tian Hao Zhu,Tina Bhutani,Wilson Liao +11 more
TL;DR: It is shown that consumption of particular types of food produces predictable shifts in existing host bacterial genera, which affects host immune and metabolic parameters, with broad implications for human health.
Journal ArticleDOI
Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization
Hsin-Wen Chang,Di Yan,Di Yan,Rasnik Singh,Rasnik Singh,J. Liu,Xueyan Lu,Xueyan Lu,Derya Ucmak,Derya Ucmak,Kristina Lee,Ladan Afifi,Ladan Afifi,Douglas Fadrosh,John Leech,Kimberly S. Vasquez,Margaret M. Lowe,Michael Rosenblum,Tiffany C. Scharschmidt,Susan V. Lynch,Wilson Liao +20 more
TL;DR: The results suggest that microbial communities on psoriatic skin is substantially different from those on healthy skin, and the psoriasis-associated skin microbiome has increased diversity and reduced stability compared to the healthy skin microbiome.
Journal ArticleDOI
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials.
Benjamin Farahnik,Kourosh Beroukhim,Michael Abrouk,Mio Nakamura,Tian Hao Zhu,Rasnik Singh,Kristina Lee,Tina Bhutani,John Koo +8 more
TL;DR: Use of brodalumab revealed prompt clinical improvement and a favorable short-term safety profile in phase III trials, although further extension studies are needed to assess long- term safety.
Journal ArticleDOI
The role of IL-17 in vitiligo: A review
Rasnik Singh,Kristina Lee,Ivan Vujkovic-Cvijin,Derya Ucmak,Benjamin Farahnik,Michael Abrouk,Mio Nakamura,Tian Hao Zhu,Tina Bhutani,Maria L. Wei,Wilson Liao +10 more
TL;DR: Current understanding of how IL-17 may influence the pathogenesis of autoimmune vitiligo at the molecular level is synthesized and has implications for defining new Vitiligo biomarkers and treatments.
Journal ArticleDOI
Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Adi Nosrati,Adi Nosrati,Jacqueline G. Berliner,Jacqueline G. Berliner,S. Goel,Joseph McGuire,Vera Morhenn,Juliana Rocha de Souza,Yıldıray Yeniay,Rasnik Singh,Kristina Lee,Mio Nakamura,Rachel R. Wu,Ann Griffin,Barbara Grimes,Eleni Linos,Mary-Margaret Chren,Mary-Margaret Chren,Roy C. Grekin,Maria L. Wei,Maria L. Wei +20 more
TL;DR: No significant differences were found in the recurrence rate, overall survival, or melanoma-specific survival of patients with MIS treated with MMS compared with WLE.